The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype

Clinical Biochemistry

Volumn 34, Issue 2, 2001, Pages 161-

  Liberopoulos, Evagelos ^a   Pavlidis, Nicholas ^a   Elisaf, Moses ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAMOXIFEN;

ALLELE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LETTER; LIPID BLOOD LEVEL; PHENOTYPE; PRIORITY JOURNAL;

ALLELES; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; BLOOD; CHOLESTEROL, HDL; FEMALE; HUMANS; PHENOTYPE; TAMOXIFEN;

EID: 0035043962     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00197-7     Document Type: Letter

References (9)

1. Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy
2. Apolipoprotein E. polymorphism, and atherosclerosis
3. Apolipoprotein E polymorphism in men and women from a Spanish population: Allele frequencies and influence on plasma lipids and apolipoproteins
4. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol
5. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA inhibitor therapy
6. The beneficial effect oftamoxifen on serum lipoprotein-A levels: An additional anti-atherogenic property
7. Long term effects of tamoxifen on blood lipid values in breast cancer
8. Regulation of hepatic apolipoprotein synthesis in the 17 a-ethinyl estradiol-treated rat
9. Influence of development, estrogens and food intake on apolipoprotein A-1, A-III, and E mRNA in rat liver and intestine